Bookmark and Share
BioAssay: AID 504623

Orthogonal assay for the inhibition of tumorsphere formation Measured in Cell-Based System Using Imaging - 2058-03_Inhibitor_SinglePoint_DryPowder_Activity

Assay Overview: The objective of these experiments is to identify chemical compounds that can selectively kill breast cancer stem cells (CSCs). Compounds identified in previous assays that selectively killed breast cancer stem cell-like cells were tested for inhibition of in vitro tumor models, tumorspheres or mammospheres. One thousand SUM159 cells are plated in 200 uL of media with 0.5% more ..
_
   
 Tested Compounds
 Tested Compounds
All(16)
 
 
Active(4)
 
 
Inactive(10)
 
 
Inconclusive(2)
 
 
 Tested Substances
 Tested Substances
All(16)
 
 
Active(4)
 
 
Inactive(10)
 
 
Inconclusive(2)
 
 
 Related BioAssays
 Related BioAssays
AID: 504623
Data Source: Broad Institute (2058-03_Inhibitor_SinglePoint_DryPowder_Activity)
BioAssay Type: Confirmatory, Concentration-Response Relationship Observed
Depositor Category: NIH Molecular Libraries Probe Production Network
Deposit Date: 2011-03-30
Hold-until Date: 2012-03-29
Modify Date: 2012-03-30

Data Table ( Complete ):           View Active Data    View All Data
BioActive Compounds: 4
Related Experiments
Show more
AIDNameTypeProbeComment
2721Summary of Broad Institute MLPCN Breast Cancer Stem Cell Toxicity ProjectSummary4 depositor-specified cross reference: Summary assay
2717Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem CellsScreening same project related to Summary assay
449748Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem CellsConfirmatory same project related to Summary assay
463074Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFPConfirmatory same project related to Summary assay
493176Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells Measured in Cell-Based System Using Plate Reader - 2058-01_Inhibitor_Dose_DryPowder_Activity_Set3Confirmatory same project related to Summary assay
493196HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP Measured in Cell-Based System Using Plate Reader - 2058-02_Inhibitor_Dose_DryPowder_Activity_Set3Confirmatory same project related to Summary assay
493226Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells Measured in Cell-Based System Using Plate Reader - 2058-01_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatory same project related to Summary assay
504325HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP Measured in Cell-Based System Using Plate Reader - 2058-02_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatory same project related to Summary assay
504449Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells Measured in Cell-Based System Using Plate Reader - 2058-01_Inhibitor_Dose_DryPowder_Activity_Set4Confirmatory same project related to Summary assay
504450HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP Measured in Cell-Based System Using Plate Reader - 2058-02_Inhibitor_Dose_DryPowder_Activity_Set4Confirmatory same project related to Summary assay
504533HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP Measured in Cell-Based System Using Plate Reader - 2058-02_Inhibitor_Dose_DryPowder_Activity_Set5Confirmatory same project related to Summary assay
504535Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells Measured in Cell-Based System Using Plate Reader - 2058-01_Inhibitor_Dose_DryPowder_Activity_Set5Confirmatory same project related to Summary assay
504666HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP Measured in Cell-Based System Using Plate Reader - 2058-02_Inhibitor_Dose_DryPowder_Activity_Set6Confirmatory same project related to Summary assay
504667Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells Measured in Cell-Based System Using Plate Reader - 2058-01_Inhibitor_Dose_DryPowder_Activity_Set6Confirmatory same project related to Summary assay
504788Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells Measured in Cell-Based System Using Plate Reader - 2058-01_Inhibitor_Dose_DryPowder_Activity_Set7Confirmatory same project related to Summary assay
504789HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP Measured in Cell-Based System Using Plate Reader - 2058-02_Inhibitor_Dose_DryPowder_Activity_Set7Confirmatory same project related to Summary assay
504859Orthogonal assay for the inhibition of tumorsphere formation Measured in Cell-Based System Using Imaging - 2058-03_Inhibitor_SinglePoint_DryPowder_Activity_Set2Other same project related to Summary assay
588702Luminescence-based toxicity of Human Mammary Epithelial (HMLE) cells_2058-08_Inhibitor_Dose_DryPowder_ActivityConfirmatory same project related to Summary assay
588703Luminescence-based toxicity of HMLE_shTWIST Breast Cancer Stem Cell-like cells_2058-07_Inhibitor_Dose_DryPowder_ActivityConfirmatory same project related to Summary assay
588704Luminescence-based toxicity of HMLE_shECAD Breast Cancer Stem Cell-like cells_2058-06_Inhibitor_Dose_DryPowder_ActivityConfirmatory same project related to Summary assay
588705Luminescence-based toxicity of MDA231 Breast Cancer cells_2058-09_Inhibitor_Dose_DryPowder_ActivityConfirmatory same project related to Summary assay
588840uminescence-based toxicity of MDA231 Breast Cancer cells Measured in Cell-Based System Using Plate Reader - 2058-09_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatory same project related to Summary assay
588844Luminescence-based toxicity of HMLE_shECAD Breast Cancer Stem Cell-like cells Measured in Cell-Based System Using Plate Reader - 2058-06_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatory same project related to Summary assay
588845Luminescence-based toxicity of HMLE_shTWIST Breast Cancer Stem Cell-like cells Measured in Cell-Based System Using Plate Reader - 2058-07_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatory same project related to Summary assay
588846Luminescence-based toxicity of Human Mammary Epithelial (HMLE) cells Measured in Cell-Based System Using Plate Reader - 2058-08_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatory same project related to Summary assay
Description:
Keywords: Tumorsphere, mammosphere, tumor, breast cancer stem cells, SUM159

Assay Overview: The objective of these experiments is to identify chemical compounds that can selectively kill breast cancer stem cells (CSCs). Compounds identified in previous assays that selectively killed breast cancer stem cell-like cells were tested for inhibition of in vitro tumor models, tumorspheres or mammospheres. One thousand SUM159 cells are plated in 200 uL of media with 0.5% methylcellulose containing 200nl previously added compounds. Tumorspheres are allowed to form for 9 days and imaged in transmitted light using a 2x objective. Images are subsequently analyzed using MetaXpress (Molecular Devices) to quantify numbers of tumorspheres formed. Compounds found to inhibit tumorsphere formation would be interesting for new drug candidates for anti-cancer therapy. Compounds identified would also serve as useful probes to study CSC biology, which are currently lacking.

Expected Outcome: Compounds significantly suppressing tumrosphere formation.
Protocol
Regents:

SUM159 media:
F12/DMEM 465 ml
25 ml FBS (5% final)
5 ml Pen/Strep (1%)
5 ml Glutamax (1%)
600 ul Insulin
500 ul Gentamicin
250 ul Plasmocin750 Hydrocortisone

SUM159 (primary tumor cell line) were provided collaborators Dr. Piyush Gupta & Dr. Eric Lander, as described in Breast Cancer Research 2008, 10:R25. Cells are propagated in SUM159 media at 37 degrees C, 5% CO2 .

Protocol:

On the day of the experiment, 96 well, Costar Ultra Low Cluster (3474) plates are filled with 100ul of SUM159 Media using a Thermo Scientific Multidrop Combi with a standard sized cassette. Compounds are pinned (200 nL, 2 dips of 100 nl) to media alone. Confluent cells grown in T225 flasks are split, collected, and spun at 1200rpm for 5 min. Trypsin is aspirated and cells are resuspended in media. Cells are counted and diluted into media with final concentration of 1% MethylCellulose (1:2.6 dilution) to 20,000 cells/ml.

100 ul of cells+methylcellulose mixture is added into each well of the 96-well plates pre-aliquoted with compounds, using a Thermo Scientific Multidrop Combi with a standard sized cassette. The final concentration is 0.5% Methylcellulose and 1000 cells/well.

The plates are incubated at 37 degrees C, 5% CO2 for 8 days. Imaging was performed using a 2x objective using an ImageXpress Micro (Molecular Devices) to collect 9 sites/well. Cell clusters greater than 400 square uM were identified as tumorspheres, using MetaXpress software.
Comment
PRESENCE OF CONTROLS: Neutral control wells (NC) and positive control wells (PC) were included on every plate.

EXPECTED OUTCOME: Active compounds result in decreasing readout signal.
NORMALIZATION:
The raw signals of the plate wells were normalized using the 'Neutral Controls Minus Inhibitors' method in Genedata Assay Analyzer (v7.0.3):
The median raw signal of the intraplate neutral control wells was set to a normalized activity value of 0.
The median raw signal of the intraplate positive control wells was set to a normalized activity value of -100.
Experimental wells values were scaled to this range.
PATTERN CORRECTION: No plate pattern correction algorithm from Genedata Condoseo (v.7.0.3) was applied.

PUBCHEM_ACTIVITY_SCORE:
This was set as equal to the mean of the normalized sample replicate activities, rounded to the nearest integer .
The minimum PUBCHEM_ACTIVITY_SCORE required for a compound to be called a hit (the activity threshold, or AT) was set at -25.

PERCENTAGE OF ACTIVE REPLICATES:
For each sample, the percentage of replicates (PCT_ACTIVE_REP) which had activity scores >= AT was determined.
The minimum percentage of replicates required for a compound to be called a hit (PAR_T) was set at 60.

PUBCHEM_ACTIVITY_OUTCOME:
Samples passing BOTH threshold criteria were assigned an outcome of 2 (active):
PUBCHEM_ACTIVITY_SCORE >= AT, and PCT_ACTIVE_REP >= PAR_T

Samples passing NEITHER threshold criteria were assigned an outcome of 1 (inactive):
PUBCHEM_ACTIVITY_SCORE < AT, and PCT_ACTIVE_REP < PAR_T

Samples passing AT only were assigned an outcome of 3 (inconclusive) :
PUBCHEM_ACTIVITY_SCORE >= AT, and PCT_ACTIVE_REP < PAR_T

Samples passing PAR_T only were assigned an outcome of 3 (inconclusive) :
PUBCHEM_ACTIVITY_SCORE < AT, and PCT_ACTIVE_REP >= PAR_T
Categorized Comment - additional comments and annotations
From PubChem:
Assay Format: Cell-based
Assay Cell Type: SUM159
Result Definitions
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1REPRODUCIBILITY_COSINE_TRANSFORMA measure of how well the activity reproduced across the two samples. Computed as the absolute value of the cosine between the 'replicate vector' (ScoreA, ScoreB ---as well as ScoreC and/or ScoreD where applicable) and the vector (1, 1) representing perfect reproducibility. NULL will appear in this column if a sample was not run in duplicate or if the data produced by one of the replicates was Invalid
Float
2REPLICATE_A_ACTIVITY_SCORE_25uM_(%) (25μM**)The calculated activity for the indicated sampleFloat%
3REPLICATE_B_ACTIVITY_SCORE_25uM_(%) (25μM**)The calculated activity for the indicated sampleFloat%
4REPLICATE_C_ACTIVITY_SCORE_25uM_(%) (25μM**)The calculated activity for the indicated sampleFloat%

** Test Concentration.
Additional Information
Grant Number: 1R03MH089663-01

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
PageFrom: